Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Dexcom (DXCM) over the last 13 years, with Q4 2025 value amounting to $405.5 million.

  • Dexcom's Shares Outstanding (Diluted Average) fell 174.46% to $405.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $405.5 million, marking a year-over-year decrease of 174.46%. This contributed to the annual value of $405.5 million for FY2025, which is 174.46% down from last year.
  • According to the latest figures from Q4 2025, Dexcom's Shares Outstanding (Diluted Average) is $405.5 million, which was down 174.46% from $407.7 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Shares Outstanding (Diluted Average) ranged from a high of $431.5 million in Q2 2023 and a low of $104.6 million during Q1 2021
  • Over the past 5 years, Dexcom's median Shares Outstanding (Diluted Average) value was $422.0 million (recorded in 2023), while the average stood at $404.9 million.
  • As far as peak fluctuations go, Dexcom's Shares Outstanding (Diluted Average) skyrocketed by 34030.93% in 2021, and later tumbled by 338.35% in 2024.
  • Over the past 5 years, Dexcom's Shares Outstanding (Diluted Average) (Quarter) stood at $428.8 million in 2021, then decreased by 0.3% to $427.5 million in 2022, then dropped by 0.47% to $425.5 million in 2023, then decreased by 3.01% to $412.7 million in 2024, then dropped by 1.74% to $405.5 million in 2025.
  • Its last three reported values are $405.5 million in Q4 2025, $407.7 million for Q3 2025, and $408.2 million during Q2 2025.